HOME >> MEDICINE >> NEWS
Unrestricted metabolic research grant awarded to Beth Israel Deaconess

PRINCETON, NJ -- Bristol-Myers Squibb has awarded a five-year $500,000 Unrestricted Metabolic Research Grant to Beth Israel Deaconess Medical Center in Boston for research investigating the mechanisms of insulin action and resistance, the molecular and cellular aspects of obesity, and the relationship of obesity to type II diabetes.

Jeffrey S. Flier, M.D., whose research in diabetes and obesity has led to a greater understanding of insulin and leptin resistance, and to obesity's role in causing the metabolic syndrome (characterized by abdominal obesity, insulin-resistant diabetes, hyperlipidemia and hypertension), will serve as supervisor and principal investigator of the grant. Dr. Flier is Chief Academic Officer of Beth Israel Deaconess Medical Center and George C. Reisman Professor of Medicine at Harvard Medical School.

Simeon Taylor, M.D., Ph.D., vice president of Cardiovascular and Metabolics Discovery Biology at Bristol-Myers Squibb Pharmaceutical Research Institute in Princeton, New Jersey, presented a commemorative plaque and a symbolic check for $500,000 to Dr. Flier at a reception on October 1, 2003 at the Medical Center. Guests included Paul Levy, president and CEO of Beth Israel Deaconess Medical Center, Dr. Joseph Martin, dean of Harvard Medical School, and faculty and staff.

Dr. Taylor praised the discoveries and insights provided by Dr. Flier in the field of metabolic research. "Through his discovery of autoantibodies to the insulin receptor and mutations of the insulin receptor gene, Dr. Flier identified one of the mechanisms responsible for insulin resistance," said Dr. Taylor. "He used transgenic and gene knockout models to test hypotheses regarding insulin resistance and the role of brown adipose tissue in the pathogenesis of obesity. Recently, he and his group have clarified the mechanism of action and physiologic role of the fat-derived hormone leptin. They have demonstrated that leptin not only regulates appetite, but also
'"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
2-Oct-2003


Page: 1 2 3

Related medicine news :

1. Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women
2. Exercise combats metabolic syndrome in older adults
3. Heavy, lifetime alcohol users may be toasting metabolic syndrome
4. Weight loss surgery can help reduce metabolic syndrome in obese patients
5. Abdominal fat indicates severity of metabolic syndrome in obese, postmenopausal women
6. CRESTOR leads in 1st international prospective study of statins in the metabolic syndrome
7. Diabetes drug improves metabolic changes associated with HIV combination therapy
8. Emory conference to educate health professionals about metabolic syndrome
9. Overweight Hispanic youth face increased risk of diabetes, metabolic syndrome
10. UCSD, Salk researchers define role of abnormal muscle, fat & liver in common metabolic disorder
11. Potential genetic links discovered between metabolic syndrome, diabetes and cardiovascular disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2020)... ... January 10, 2020 , ... WellHaven Pet Health, a ... in a new online community coming in February 2020, LEAD WELL with WOMEN. The ... Wellbeing Village. , The vision of LEAD WELL with WOMEN is to empower women, ...
(Date:1/10/2020)... ... January 10, 2020 , ... SMG3Rx, a clinical ... be attending the HIMSS (Healthcare Information and Management Systems Society) Global Conference & ... health information and technology event of the year, where professionals throughout the global ...
(Date:1/8/2020)... ... January 08, 2020 , ... ... sciences teams, announced today that the company is rebranding as Red Nucleus R&D, ... and performance solutions for the life sciences industry. , The addition of ...
(Date:1/8/2020)... ... January 09, 2020 , ... Real ... Webinar, Thursday, Jan. 23, 2020 • 1:30-3:00 p.m. EST, https://www.centerwatch.com/rweanddata ... (RWD) to generate evidence and identify gaps and challenges when conducting trials? The ...
(Date:1/7/2020)... ... January 07, 2020 , ... G-CON Manufacturing, ... to the company’s 200,000 sq. ft. manufacturing site in College Station, TX. The ... dedicated to POD architectural, mechanical, electrical and automation fit out. , “This facility ...
Breaking Medicine News(10 mins):
(Date:1/8/2020)... Mich. (PRWEB) , ... January 08, 2020 , ... ... leader in FDA compliance consulting, is proud to announce the attainment of a ... Council, a regional certifying partner of the Women’s Business Enterprise National Council (WBENC). ...
(Date:1/8/2020)... ... January 09, 2020 , ... ... partner practices a complimentary freezer program. The cryogenic freezer allows practices to have ... top stem cell and exosome biologics require cryogenic freezing. This may include a ...
(Date:1/7/2020)... ... 2020 , ... Myant Inc., the pioneers in Textile Computing™, will be showcasing ... CES 2020 (January 7-10, Las Vegas), including apparel from the Skiin Connected Health & ... of the CES 2020 Innovation Awards. , While electrocardiography, or the study of the ...
Breaking Medicine Technology:
Cached News: